309 related articles for article (PubMed ID: 8637234)
21. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia.
Okuda T; Shurtleff SA; Valentine MB; Raimondi SC; Head DR; Behm F; Curcio-Brint AM; Liu Q; Pui CH; Sherr CJ
Blood; 1995 May; 85(9):2321-30. PubMed ID: 7727766
[TBL] [Abstract][Full Text] [Related]
22. Homozygous deletions of the CDKN2 (MTS1/p16ink4) gene in cell lines established from children with acute lymphoblastic leukemia.
Zhou M; Gu L; James CD; He J; Yeager AM; Smith SD; Findley HW
Leukemia; 1995 Jul; 9(7):1159-61. PubMed ID: 7630190
[TBL] [Abstract][Full Text] [Related]
23. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
Tahara H; Smith AP; Gaz RD; Arnold A
J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819
[TBL] [Abstract][Full Text] [Related]
24. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
25. Deletion or lack of expression of CDKN2 (CDK4I/MTS1/INK4A) and MTS2 (INK4B) in acute lymphoblastic leukemia cell lines reflects the phenotype of the uncultured primary leukemia cells.
Jagasia AA; Sher DA; Le Moine PJ; Kim DH; Moldwin RL; Smith SD; Diaz MO
Leukemia; 1996 Apr; 10(4):624-8. PubMed ID: 8618438
[TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias.
Hayette S; Thomas X; Bertrand Y; Tigaud I; Callanan M; Thiebaut A; Charrin C; Archimbaud E; Magaud JP; Rimokh R
Leukemia; 1997 Oct; 11(10):1696-9. PubMed ID: 9324291
[TBL] [Abstract][Full Text] [Related]
27. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
28. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
29. Absence of p18 mutations or deletions in lymphoid malignancies.
Otsuki T; Jaffe ES; Wellmann A; Kumar S; Condron KS; Raffeld M
Leukemia; 1996 Feb; 10(2):356-60. PubMed ID: 8637248
[TBL] [Abstract][Full Text] [Related]
30. Acquisition of p16(INK4A) and p15(INK4B) gene abnormalities between initial diagnosis and relapse in children with acute lymphoblastic leukemia.
Maloney KW; McGavran L; Odom LF; Hunger SP
Blood; 1999 Apr; 93(7):2380-5. PubMed ID: 10090949
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
Herman JG; Jen J; Merlo A; Baylin SB
Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
[TBL] [Abstract][Full Text] [Related]
32. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
34. Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations.
Maloney KW; McGavran L; Odom LF; Hunger SP
Leukemia; 1998 Sep; 12(9):1417-21. PubMed ID: 9737691
[TBL] [Abstract][Full Text] [Related]
35. Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas.
Li YJ; Hoang-Xuan K; Delattre JY; Poisson M; Thomas G; Hamelin R
Oncogene; 1995 Aug; 11(3):597-600. PubMed ID: 7630644
[TBL] [Abstract][Full Text] [Related]
36. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma.
Elenitoba-Johnson KS; Gascoyne RD; Lim MS; Chhanabai M; Jaffe ES; Raffeld M
Blood; 1998 Jun; 91(12):4677-85. PubMed ID: 9616165
[TBL] [Abstract][Full Text] [Related]
37. Allelotype analysis in relapsed childhood acute lymphoblastic leukemia.
Takeuchi S; Seriu T; van Dongen JJ; Szczepański T; Tsukasaki K; Takeuchi N; Fermin AC; Seo H; Bartram CR; Koeffler HP
Oncogene; 2003 Oct; 22(44):6970-6. PubMed ID: 14534546
[TBL] [Abstract][Full Text] [Related]
38. P16INK4A gene homozygous deletions in human acute leukaemias with alterations of chromosome 9.
Faienza MF; della Ragione F; Basso G; Coppola B; Miraglia del Giudice E; Schettini F; Iolascon A
Br J Haematol; 1996 Jun; 93(3):632-6. PubMed ID: 8652384
[TBL] [Abstract][Full Text] [Related]
39. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies.
Ogawa S; Hangaishi A; Miyawaki S; Hirosawa S; Miura Y; Takeyama K; Kamada N; Ohtake S; Uike N; Shimazaki C
Blood; 1995 Aug; 86(4):1548-56. PubMed ID: 7632963
[TBL] [Abstract][Full Text] [Related]
40. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
